B
PRCT icon

Bailard’s Procept Biorobotics PRCT Stock Holding History

Bailard’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,126
Closed -$326K – 851
2025
Q3 		$326K Hold
9,126
– – 0.01% 587
2025
Q2 		$526K Sell
9,126
-1,260
-12% -$71.2K 0.01% 480
2025
Q1 		$605K Sell
10,386
-1,000
-9% -$68.3K 0.02% 422
2024
Q4 		$917K Sell
11,386
-2,000
-15% -$171K 0.02% 309
2024
Q3 		$1.07M Sell
13,386
-5,000
-27% -$355K 0.03% 294
2024
Q2 		$1.12M Sell
18,386
-3,000
-14% -$178K 0.03% 274
2024
Q1 		$1.06M Buy
+21,386
New +$1.02M 0.03% 296

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bailard's PRCT Position: Q4 2025 in Review

Bailard sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 9,126 shares — an estimated $326K sold.

Bailard first reported a position in PRCT in Q1 2024 and held it in 7 quarters. The position peaked at $1.12M in Q2 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Bailard reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Bailard sold 9,126 Procept Biorobotics shares in Q4 2025, an estimated $326K.
  • Bailard first reported a position in Procept Biorobotics in Q1 2024 and held it in 7 quarters.
  • Bailard's Procept Biorobotics position peaked at $1.12M in Q2 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Bailard's 13F filing for Q4 2025, filed 4 Feb 2026.